Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Free Report)’s share price crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0020. Sorrento Therapeutics shares last traded at $0.0011, with a volume of 334,705 shares trading hands.
Sorrento Therapeutics Stock Down 15.4%
The firm has a market cap of $606,408.00, a price-to-earnings ratio of -0.01 and a beta of 0.10.
Sorrento Therapeutics Company Profile
Sorrento Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the development of therapies in immuno-oncology, inflammatory diseases and pain management. Leveraging proprietary antibody, small molecule and cell therapy platforms, Sorrento aims to advance next-generation treatment candidates that address unmet medical needs in oncology and chronic pain without reliance on traditional opioids.
The company’s immuno-oncology pipeline encompasses monoclonal antibodies, antibody-drug conjugates and engineered cell therapies designed to target solid tumors and hematologic malignancies.
Read More
- Five stocks we like better than Sorrento Therapeutics
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
